FDA Public Advisory for Nevirapine (Viramune)

No abstract available.

Bibliographic Details
Main Author: Editorial Office
Format: Article
Language:English
Published: AOSIS 2005-05-01
Series:Southern African Journal of HIV Medicine
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/591
_version_ 1811291343265202176
author Editorial Office
author_facet Editorial Office
author_sort Editorial Office
collection DOAJ
description No abstract available.
first_indexed 2024-04-13T04:27:49Z
format Article
id doaj.art-a32b89cc352949e58f6b87c6bfe0510a
institution Directory Open Access Journal
issn 1608-9693
2078-6751
language English
last_indexed 2024-04-13T04:27:49Z
publishDate 2005-05-01
publisher AOSIS
record_format Article
series Southern African Journal of HIV Medicine
spelling doaj.art-a32b89cc352949e58f6b87c6bfe0510a2022-12-22T03:02:27ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512005-05-016110.4102/sajhivmed.v6i1.591457FDA Public Advisory for Nevirapine (Viramune)Editorial Office0Southern African Journal of HIV MedicineNo abstract available.https://sajhivmed.org.za/index.php/hivmed/article/view/591
spellingShingle Editorial Office
FDA Public Advisory for Nevirapine (Viramune)
Southern African Journal of HIV Medicine
title FDA Public Advisory for Nevirapine (Viramune)
title_full FDA Public Advisory for Nevirapine (Viramune)
title_fullStr FDA Public Advisory for Nevirapine (Viramune)
title_full_unstemmed FDA Public Advisory for Nevirapine (Viramune)
title_short FDA Public Advisory for Nevirapine (Viramune)
title_sort fda public advisory for nevirapine viramune
url https://sajhivmed.org.za/index.php/hivmed/article/view/591
work_keys_str_mv AT editorialoffice fdapublicadvisoryfornevirapineviramune